Merck stops study of HIV vaccine
A worldwide Phase II trial of a Merck HIV vaccine was halted after an independent reviewer found the vaccine ineffective, the firm said.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.